Acrivastine and pseudoephedrine and Aprepitant Capsules
Determining the interaction of Acrivastine and pseudoephedrine and Aprepitant Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: acrivastine / pseudoephedrine
Brand name: Semprex-D
Synonyms: Acrivastine and Pseudoephedrine
Generic Name: aprepitant
Brand name: Cinvanti, Emend, Emend 3-Day, Emend 2-Day
Synonyms: Aprepitant
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Acrivastine and pseudoephedrine-Aprepitant Injection
- Acrivastine and pseudoephedrine-Aprepitant Intravenous
- Acrivastine and pseudoephedrine-Aprepitant Oral Suspension
- Acrivastine and pseudoephedrine-Aprepitant/Fosaprepitant Dimeglumine
- Acrivastine and pseudoephedrine-Apresazide
- Acrivastine and pseudoephedrine-Apresoline
- Aprepitant Capsules-Actamin
- Aprepitant Capsules-Actamin Maximum Strength
- Aprepitant Capsules-Actemra
- Aprepitant Capsules-Actemra (Tocilizumab (Intravenous))
- Aprepitant Capsules-Actemra (Tocilizumab Auto-Injectors)
- Aprepitant Capsules-Actemra (Tocilizumab Prefilled Syringes)